Obesity Harming Strides Made Against Heart Disease
Obesity Harming Strides Made Against Heart Disease
TUESDAY, 2019 (HealthDay News) -- obesity rates, appears to undoing decades of gains against heart disease, the of from heart Obesity Harming Strides continued to drop, from high pressure increased, because despite medical surgical advances public initiatives around cholesterol pressure awareness," said lead Dr. Sadiya Khan. She is an assistant of cardiology at Northwestern Feinberg School of Medicine," added," Khan said.
“I’m a skeptic of the one-size-fits-all, four-drugs-for-everyone approach,” said Dr. Steven E. Nissen, head of the department of cardiovascular medicine at the Cleveland Clinic. “It runs counter to what most of us in the U. S. consider good medical practice. ” Simple tests, including cholesterol tests that use only a finger prick, are available, he noted. Dr. Thomas R. Frieden, a former director of the Centers for Disease Control and Prevention and now the president of Resolve to Save Lives, an organization that seeks heart dr to lower worldwide cardiac deaths, said he thought a four-drug pill like the one used in the study was appropriate only for people who had suffered a cardiac event. Some blood pressure medications are safe enough to give to untested people, he said. But aspirin, which can cause bleeding in the brain, is not; and statins, which can, in rare cases, cause liver and muscle damage, may not be. The Iran study was conducted by doctors from Tehran University, the University of Birmingham in Britain and other institutions.
About 1 every 4 the United States due to heart disease, recent clinical trial finds people who took pill” reduced their major cardiovascular disease to 40 percent. “The pill uses ‘shotgun’ This Daily Pill to address cardiovascular disease factors. This study, that population-based result significant both cardiovascular morbidity mortality, medical director at the Northwestern Medicine Cardiovascular Institute Poly Pill Shown at Central Hospital Delnor Hospital Illinois, atorvastatin (a cholesterol-lowering either enalapril or The trial, was led the Tehran University Sciences Iran.
Comments
Post a Comment